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Pathogenesis of Varicose Veins
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Background: varicose veins are present in up to 40% of the population. They may be associated with considerable
morbidity. Around 70% of patients with chronic venous insufficiency have evidence of superficial venous incompetence
on duplex imaging.
Methods: in this publication we review the evidence available regarding the pathogenesis of varicose veins.
Results: a number of theories have been suggested. The present data suggests that abnormalities in the venous endothelium
and smooth muscle cells result in vein wall dilatation with secondary valvular incompetence. However, there is also
evidence to support acquired venous valve failure. Congenital venous valve abnormalities have not been well studied.
Conclusion: further work is required on this relatively neglected topic. The use of improved imaging such as high-
resolution ultrasound is likely to significantly improve our understanding of venous valve function and pathology.
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Introduction
Varicose veins (tortuous, twisted, or lengthened veins)
are present in 10±40% of 30±70 year old people.1,2 The
majority of patients associate their varicose veins with
a number of symptoms, including cosmetic embar-
rassment, leg aching, puritus and skin rashes,
although the exact relationship between such com-
plaints and objective varicosity is far from clear.1,2 A
proportion of patients will go on to develop serious
complications of their varicose veins, including super-
ficial or deep thrombosis, skin thickening and staining
(lipodermatosclerosis), haemorrhage from a superfi-
cial varicosity or ulceration.3 The exact incidence of
these complications in patients with varicose veins is
not known for a number of reasons. Firstly, the great
majority of the population with this condition do not
present for medical treatment. Secondly, longitudinal
studies of patients with uncomplicated varicose veins
are rare and would need to be large and over a period
of 20 years or more to provide this information.
Lower limb ulceration is responsible for consider-
able morbidity and health cost.4 Around 70% of lower
limb ulcers are due to venous disease.5 The aetiology
of skin damage in venous disease is incompletely
understood,however,venoushypertensionconsequent
on venous valve incompetence is believed to be of
paramount importance.6 Therefore, at present the
management of varicose veins principally rests on
the identification and treatment of valvular incompe-
tence. Duplex ultrasound studies demonstrate that
30% of patients with venous ulcers have superficial
venous incompetence only, while a further 40% have
superficial reflux in combination with deep vein
valvular incompetence.7 Despite large numbers of
ultrasound studies on patients with venous insuffi-
ciency relatively little work has been concentrated on
the pathogenesis of the venous disease.
Methods
Data from papers dealing with varicose vein patho-
genesis were sought by searches performed on
PUBMED and MEDLINE. In addition hand searching
based on references from identified publications was
carried out. Due to the diverse nature of techniques
that may be used to provide evidence for varicose
veins pathogenesis wide search criteria were
employed. Keywords used were varicose veins,
pathogenesis, pathology, endothelium, smooth mus-
cle, duplex, and epidemiology. Numerous publica-
tions dealing with duplex imaging were identified
but only selected for further assessment if they pro-
vided evidence to support or refute one of the theories
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of varicose veins pathogenesis. Relatively few papers
dealing with the vascular biology of venous disease
were identified and these were all included for
detailed assessment.
Epidemiology
For a detailed discussion of the epidemiology of vari-
cose veins readers are referred to an excellent review.2
The suggested risk factors for varicose veins include
female gender, age, pregnancy, family history, race,
occupation, obesity and diet.8±11 Firm conclusions
regarding the importance of these factors in the aeti-
ology of varicose veins is hampered by the variable
methods which have been used to define varicose
veins, sample the population and record risk factors.2
Critical analysis of the data available on epidemiology
suggests that older age, multiple pregnancies and
Caucasian race are the most well supported risk fac-
tors for varicose veins.2 Most studies have suggested
varicose veins are more common in women, with a
female to male ratio of between 1.5:1 and 3:1.2 How-
ever, a recent study by Evans and colleagues reported
equal incidence of varicose veins in men and women.8
There is little evidence to support other factors such as
family history and occupation.2 The recent Edinburgh
vein study investigated 1566 men and women and
found a weak association between standing, straining
at stool, and height with superficial venous reflux.12
The importance of these factors in the development of
varicose veins is difficult to clearly define as studies
have given conflicting findings. The authors of
the Edinburgh vein study concluded that there were
no strong and consistent life style risk factors for
venous reflux.12
Lessons from duplex studies: What is the relationship
between deep and superficial reflux and what is the
role of thrombosis in superficial reflux?
Classically varicose veins arising as a result of an
identified cause such as previous DVT are referred to
as secondary. However, in the majority of cases there
is no identifiable cause for the development of the
varicose veins, which are therefore referred to as
primary. It is normal for blood to flow down the
superficial or deep veins for up to a second under
conditions that stimulate valve closure, such as stand-
ing.13 The cut off point at which incompetence is
defined is rather arbitrary. However, studies in normal
people suggest that 95% of `` physiological'' reflux
has stopped by 0.5 s when valvular integrity is
determined by distal compression in the standing
position.13 Hence this period of reflux is used by
many sonographers to define venous incompetence.
Using these criteria Labropoulos and colleagues
demonstrated venous incompetence in 11 of 80 normal
limbs, in patients aged 15±35 years. In people with
prominent but not varicosed veins the incidence was
as high as 77%.13 The site of reflux was distributed
throughout the leg, but the principal location was the
great saphenous vein. Studies from patients with
superficial reflux without a history or evidence of
DVT demonstrate associated deep venous reflux in
around 20% of patients.14 In some cases this reflux
appears to be limited to the region of the superficial
and deep connection, and resolves following correc-
tion of the superficial reflux.14,15
Following DVT the incidence of superficial as well
as deep reflux appears to be increased according to the
study of Meissner and colleagues.16 They carried out
repeat duplex imaging on 69 limbs in which a DVT
had occurred. Thrombus was demonstrated in the
great saphenous vein (GSV) initially in 21%. At
8 years the incidence of GSV reflux was 29% in limbs
that had developed a DVT, compared to 15% in the
contralateral limb.16 The reflux incidence was much
higher in limbs in which the initial thrombosis had
involved the GSV (77%). The importance of thrombus
as a prelude to valvular incompetence is supported by
studies following the outcome of DVT17±23 (Table 1).
These studies demonstrate early recanalisation of
thrombosed vein segments, however, valvular incom-
petence often develops at the site of thrombus forma-
tion. Reflux that develops at other sites in these
patients is likely multi-factorial, resulting from prox-
imal occlusion leading to venous dilatation, secondary
thrombosis at other sites and other primary factors
(see below). There is increasing evidence that sub-
clinical deep vein thrombosis occurs. For example in
a recent randomised controlled trial of healthy travel-
lers over 50 years of age, asymptomatic calf vein
thrombosis was detected in 10% of people not wearing
support stockings.24 It is likely that if these patients
had not been part of a duplex study this problem
would have gone undetected. Thus it is possible that
sub-clinical thrombosis involving the deep or superfi-
cial veins may have a role in the aetiology of primary
varicose veins.
Theories of primary varicose veins aetiology
Congenital or acquired valvular dysfunction
Estienne and Canano discovered the venous valves in
the 1530s.25 Initially it was suggested that valvular
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failure at the sapheno-femoral junction was the pri-
mary event with secondary failure of more distal
valves as a result of the increased pressure placed on
these sites.26 However, the finding of isolated valvular
incompetence at distal sites or tributaries disproved
this idea.14 For example Labropoulos and associates
studied the site of superficial valvular incompetence
in 139 limbs with primary reflux.14 In 24% reflux was
detected in the main trunk of the great saphenous or a
tributary without junctional incompetence. This does
not, however, rule out a primary valvular problem
that develops at a variety of sites. There have been
remarkably few pathological studies of valves in ven-
ous disease. Ono and colleagues studied great saphe-
nous vein removed from patients with duplex
demonstrated valvular incompetence.27 They found
clear valve leaflet shortening in three of seven speci-
mens examined. In addition, they demonstrated
monocyte/macrophage infiltration at valve sinuses.
These findings were absent in the four specimens of
macroscopically normal vein removed from patients
undergoing coronary bypass. Such leukocyte infiltra-
tion could be an important factor in the generation of
valve damage and development of incompetence by
the induction of fibrosis. However, it is possible that
the inflammatory focus is a secondary phenomenon,
especially as it does not appear that patients with
previous thrombophlebitis were excluded. Sub-clinical
thrombosis is another possible mechanism by which
valvular incompetence might develop. Interestingly a
recent association has been demonstrated between
polymorphism in the gene for the anticoagulant pro-
tein thrombomodulin and varicose veins.28 A more
recent pathological study of 65 proximal great saphe-
nous valves excised at varicose vein surgery demon-
strated widening of the valve annulus associated with
medial hypoplasia in the majority of cases.29 Whether
these changes result from a primary valve problem
or primary medial problem is unknown. Improved
imaging is likely to be required to resolve this issue.
A study by Yamaki and colleagues correlated the find-
ings on pre-operative duplex imaging with those
demonstrated intra-operatively by angioscopy.30 By
endoluminal imaging they defined three groups of
valve cusp abnormalities in 75% of patients and
absent sapheno-femoral valves in 25%. While duplex
could be used to detect these abnormalities with high
sensitivity, the specificity in defining the type of cusp
problem was low.30
Primary venous dilatation leading to secondary valvular
incompetence
Structural weakness of the vein wall. This theory has
recently received most support. A primary weakness
in the wall of the vein could result in dilatation of the
vein with resultant separation of valve cusps and
eventual reflux. Most authors have suggested that
this weakness would be a result of structural problems
in the wall of the vein.31±35 A number of abnormalities
in the structural proteins of the vein have been
demonstrated. These include abnormal collagen and
elastin content, intimal hyperplasia and changes in
matrix controlling enzymes, although the changes
demonstrated have varied from one study to
another.31±35 Andreotti and colleagues demonstrated
a reduction in both collagen and elastin content in
varicose compared to macroscopically normal
veins.31 They also found alterations in the collagen
content of skin taken from patients with varicose
veins and suggested a systemic collagen disorder in
varicose veins.32 In contrast, most investigators have
found an increase in the collagen content of segments
of varicose compared to normal veins.33,34 For
example, Gandhi et al. demonstrated an increase in
the collagen content, decrease in the elastin concentra-
tion, without change in the activity of proteolytic
enzymes in the wall of varicose veins.33 Sansilvestri-
Morel et al. found an imbalance in the sub-types of
collagen synthesised by smooth muscle cells derived
from varicose veins.34 Collagen type I was increased
Table 1. Selected studies of DVT by duplex imaging.
Author Limbs Follow-up
(months)
Recanalisation
(Partial or complete)
Reflux at site of
thrombosis
Reflux at
other sites
Predictors of CVI Incidence of CVI
(grade 4±6)
17 70 24 99% NA NA Proximal thrombus, greater
thrombus and maintained
outflow obstruction
30%
18 63 12 87% NA NA NA NA
19 158 12 77% NA NA NA NA
20 73 55 95% NA NA Severity of reflux 21%
21 58 (calf) 36 88% 9% 30% NA NA
22 72 120 99% 46% (proximally) 25% (proximally) NA NA
23 27 34 96% 54/120 (45%) 3/40 (8%) NA NA
NAnot available.CVIChronic venous insufficiency, grade 4±6 by the CEAP classification.
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while type III was decreased. Badier-Commander and
colleagues recently investigated the concentration of
enzymes regulating the extracellular matrix in speci-
mens from patients with varicose veins.35 They dis-
covered a relatively high concentration of the tissue
inhibitor of metalloproteinase, TIMP-1, and a relatively
low concentration of the proteolytic enzyme, metallo-
proteinase 2.35 This balance of matrix controlling
enzymes would favour the accumulation of matrix
within the wall of varicose veins. Interestingly, inflam-
mation is normally associated with a proteolytic
enzyme environment.36 Thus to date the matrix
changes demonstrated in the wall of varicose veins
have not been consistent in different studies. This
may relate to the fact that many of the pathological
findings are the result rather than the cause of the
development of varicose veins.
Impaired venous tone. Another possibility is that the
dilatation results from inability of the vein to contract
adequately as a result of smooth muscle cell or endo-
thelial dysfunction. In support of this theory a number
of abnormalities in the contraction and relaxation of
varicose vein have been demonstrated compared to
normal vein.37±41 Duplex studies suggest reduction in
vein wall elasticity in patients with varicose veins.37
Brunner et al. assessed the contraction of grossly vari-
cosed vein in comparison to vein mildly varicosed and
competent vein from the same patient.38 They discov-
ered that phenylephrine induced contraction was
absent in the overtly varicosed segments. However,
of note the incompetent but macroscopically normal
vein contracted normally, suggesting that a primary
contractile abnormality, in response to phenylepherine
at least, was not an early event in the aetiology of
valvular incompetence. Mildly varicosed segments
had normal endothelial-dependent relaxation but
reduced endothelial-independent relaxation to nitro-
prusside suggesting a global dysfunction of the
smooth muscle in varicose veins. In support of this,
in a culture model of varicose veins smooth muscle
cells appear to be heparin resistant compared to cells
from normal vein.39 Other investigators have demon-
strated reduction of endothelin B receptors in varicose
veins.40 Other functional abnormalities have also been
detected and include reduction in nitric oxide and
vascular endothelial growth factor release under con-
ditions of venous hypertension.41 Changes of venous
tone have been documented in pregnancy.42±44 Studies
using duplex imaging report an increase in diameter
of the main superficial veins from the first to the third
trimester.42,43 These diameter changes are associated
with a greater number of patients having valvular
incompetence.42,43 The changes return to baseline
after pregnancy but suggest a definite hormonal effect
on venous tone. Interestingly both oestrogen and
progesterone receptors have been demonstrated in
saphenous vein.44,45
Endothelial activation. Michaels et al. suggested that in
venous insufficiency stasis results in endothelial
hypoxia with secondary activation.46 Certainly there
is some evidence of endothelial activation in patients'
with venous disease. For example increased expres-
sion of the endothelial adhesion molecules ICAM-1
has been demonstrated in varicose veins.47 A study
by Biagi and colleagues suggested that varicose vein
produced less prostacyclin but more thromboxane A2
and prostagladin E2.48 These changes would favour
platelet activation and thrombosis. However,
Nemcova et al. were unable to confirm these findings
in a more recent study.49 In a detailed study by Badier-
Commander and associates the concentration of fibro-
blast growth factor and transforming growth factor
beta were found to be increased in atrophic varicose
veins segments.50 These changes may contribute to the
smooth muscle cell hypertrophy that occurs in some
varicose segments.
There is evidence for interaction between leuko-
cytes, platelets and the endothelium in thrombus for-
mation51 thus it is possible that alterations in the
endothelial phenotype have an important influence
in thrombosis and varicose vein formation. For
example serum levels of the adhesion molecule
VCAM-1 are elevated in patients with recent DVT.52
Interestingly experimental venous hypertension is
associated with a rise in the serum concentration of
the soluble adhesion molecules E-selectin, ICAM-1
and VCAM-1.53 This change is more marked in
patients with chronic venous insufficiency. The endo-
thelium is also fundamental in control of vasomotor
tone, for example by the production of nitric oxide,
endothelial derived hyperpolarising factor and
endothelin. Changes in endothelial derived vasoactive
compounds may also be an influential factor in the
development of varicose veins (see above).
Increased arterial inflow associated with multiple
arteriovenous communications
Arteriovenous communications in patients with vari-
cose veins have been reported in angiographic studies
and microsurgical dissections.54,55 Further support for
the presence of arteriovenous shunt in varicose veins
comes from studies reporting increased oxygen partial
pressures in the saphenous vein of varicosed com-
pared to normal veins.56,57 The inability to demon-
strate such fistulae during sapheno-femoral ligation
to treat varicose veins has led to little promotion of
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this theory and limited investigation has been carried
out to prove or refute the mechanism.
In conclusion the pathogenesis of venous disease
has been relatively under investigated. Epidemi-
ological studies have failed to show strong associa-
tions between environmental factors and varicose
veins, however, increased age, Caucasian race and
multiple pregnancies do appear to increase the risk
of varicosity. Pathological studies demonstrate
abnormalities within the venous wall in endothelial
cells, smooth muscle cells and extracellular matrix as
important mechanisms in the development of venous
incompetence. It is also likely that direct valvular
pathology occurs possibly in association with inflam-
mation and sub-clinical thrombosis. An improved
understanding of venous valvular function and path-
ology awaits increased application of modern
imaging, such as high-resolution ultrasound.
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